Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 08.06.2026 1 AJNR Am J Neuroradiol 3 J Neurol 1 J Neurol Neurosurg Psychiatry 1 J Neurol Sci 7 Mult Scler

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. VERCLYTTE S, Beaugrard G, Nickel D, Munoz-Ramirez V, et al
   Deep Learning-Accelerated 3D FLAIR Enables Reliable MS Lesion Detection.
   AJNR Am J Neuroradiol. 2026;47:1560-1568.
   PubMed         Abstract available
   
   

   
   J Neurol

2. BERGSLAND N, Burnham A, Dwyer MG, Bartnik A, et al
   Ultra-low-field MRI for bedside imaging of severe multiple sclerosis.
   J Neurol. 2026;273:364.
   PubMed         Abstract available
   
   
3. TEDONE N, Preziosa P, Pagani E, Meani A, et al
   Structural MRI signature of late- versus adult-onset multiple sclerosis: a multiparametric study.
   J Neurol. 2026;273:360.
   PubMed         Abstract available
   
   
4. BET MDA, Helmlinger B, Broeders TAA, Hechenberger SMC, et al
   Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis.
   J Neurol. 2026;273:354.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

5. PAWLITZKI M, Masanneck L, Scalfari A, Giovannoni G, et al
   Finite depletion, sustained control: can impulse therapy prevent rebound activity in multiple sclerosis?
   J Neurol Neurosurg Psychiatry. 2026 Jun 2:jnnp-2026-338914.
   PubMed        
   
   

   
   J Neurol Sci

6. ZAHRA E, Azhar A
   Letter to the editor on Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study.
   J Neurol Sci. 2026;488:126008.
   PubMed        
   
   

   
   Mult Scler

7. BENALLEGUE N, Rollot F, Iaffaldano P, Lucisano G, et al
   A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.
   Mult Scler. 2026 Jun 1:13524585261446829. doi: 10.1177/13524585261446829.
   PubMed         Abstract available
   
   
8. CORREALE J, Marrodan M, Piedrabuena MA, Soman K, et al
   Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.
   Mult Scler. 2026 Jun 1:13524585261447695. doi: 10.1177/13524585261447695.
   PubMed         Abstract available
   
   
9. LAULE C, Cohen-Adad J, Witt AA, De Luca GC, et al
   Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities.
   Mult Scler. 2026 Jun 1:13524585261444600. doi: 10.1177/13524585261444600.
   PubMed         Abstract available
   
   
10. POSER PL, Gisevius B, Tokic M, Fisse AL, et al
    Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.
    Mult Scler. 2026 Jun 1:13524585261446846. doi: 10.1177/13524585261446846.
    PubMed         Abstract available
    
    
11. SANDESJO F, McKay KA, Fink K, Piehl F, et al
    Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.
    Mult Scler. 2026 May 31:13524585261448789. doi: 10.1177/13524585261448789.
    PubMed         Abstract available
    
    
12. TALLANTYRE EC, Planchon SM, Howard H, Mays J, et al
    Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).
    Mult Scler. 2026 May 31:13524585261449988. doi: 10.1177/13524585261449988.
    PubMed         Abstract available
    
    
13. SARASTE M, Nikkila T, Matilainen M, Hamalainen P, et al
    TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.
    Mult Scler. 2026 May 31:13524585261446839. doi: 10.1177/13524585261446839.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum